Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-096517

Chief Medical Officer sold 904 shares at $14.90 ($13,470)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kerr Douglas · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-05 Sale : show line 1 in the form 10b5-1 −904 $14.90 $13,470 171,606 D
Open-market sales · 904 sh · avg $14.90 · $13,470
Loading xslF345X05/ownership.xml…